ROSANN GREGORY: Open Payments
NPI 1073743431 · MASPETH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 14 payments from 10 companies in 2025. Trend: 2023 $956 · 2024 $682 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $208 |
| Abbott Laboratories | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FARXIGA, LEQVIO, Kerendia, Ozempic, REPATHA, ELIQUIS, Rybelsus.
Industry payments across NY — which companies pay providers there.
